Lisinopril Patent Expiration
Lisinopril is Used for treating acute myocardial infarction, hypertension, and heart failure. It was first introduced by Merck Research Laboratories Div Merck Co Inc
Lisinopril Patents
Given below is the list of patents protecting Lisinopril, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Qbrelis | US10039800 | Lisinopril formulations | Nov 06, 2035 | Azurity |
Qbrelis | US10265370 | Lisinopril formulations | Nov 06, 2035 | Azurity |
Qbrelis | US10406199 | Lisinopril formulations | Nov 06, 2035 | Azurity |
Qbrelis | US10940177 | Lisinopril formulations | Nov 06, 2035 | Azurity |
Qbrelis | US11179434 | Lisinopril formulations | Nov 06, 2035 | Azurity |
Qbrelis | US11771733 | Lisinopril formulations | Nov 06, 2035 | Azurity |
Qbrelis | US9463183 | Lisinopril formulations | Nov 06, 2035 | Azurity |
Qbrelis | US9616096 | Lisinopril formulations | Nov 06, 2035 | Azurity |
Qbrelis | US9814751 | Lisinopril formulations | Nov 06, 2035 | Azurity |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Lisinopril's patents.
Latest Legal Activities on Lisinopril's Patents
Given below is the list recent legal activities going on the following patents of Lisinopril.
Event | Date | Patent/Publication |
---|---|---|
![]() | ||
Payment of Maintenance Fee, 8th Year, Large Entity | 11 Apr, 2024 | US9463183 |
Patent Issue Date Used in PTA Calculation | 03 Oct, 2023 | US11771733 |
Mail Patent eGrant Notification | 03 Oct, 2023 | US11771733 |
Recordation of Patent Grant Mailed | 03 Oct, 2023 | US11771733 |
Email Notification | 03 Oct, 2023 | US11771733 |
Recordation of Patent eGrant | 03 Oct, 2023 | US11771733 |
Patent eGrant Notification | 03 Oct, 2023 | US11771733 |
Email Notification | 15 Sep, 2023 | US11771733 |
Issue Notification Mailed | 13 Sep, 2023 | US11771733 |
Dispatch to FDC | 24 Aug, 2023 | US11771733 |
Coming Soon
Patent Strength Analyzer
![](/_nuxt/img/PatentAnalyzerAd.722976d.jpg)
YesNo
Thank you for your response 🥳
Lisinopril Generics
Several generic applications have been filed for Lisinopril. The first generic version for Lisinopril was by Heritage Pharma Labs Inc and was approved on Jul 1, 2002. And the latest generic version is by Sciegen Pharmaceuticals Inc and was approved on Mar 4, 2021.
Given below is the list of companies who have filed for Lisinopril generic.
1. HERITAGE PHARMA
Heritage Pharma Labs Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Heritage Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
30MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
40MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
2.5MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
5MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
10MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
20MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
2. HIKMA INTL PHARMS
Hikma International Pharmaceuticals Llc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Hikma Intl Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
2.5MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
5MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
10MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
20MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
40MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
30MG | tablet | Discontinued | ORAL | N/A | Jun 27, 2003 |
3. LUPIN
Lupin Ltd has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Lupin.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
30MG | tablet | Prescription | ORAL | AB | Sep 9, 2005 |
2.5MG | tablet | Prescription | ORAL | AB | Sep 9, 2005 |
5MG | tablet | Prescription | ORAL | AB | Sep 9, 2005 |
10MG | tablet | Prescription | ORAL | AB | Sep 9, 2005 |
20MG | tablet | Prescription | ORAL | AB | Sep 9, 2005 |
40MG | tablet | Prescription | ORAL | AB | Sep 9, 2005 |
4. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
20MG | tablet | Discontinued | ORAL | N/A | Jul 30, 2013 |
2.5MG | tablet | Discontinued | ORAL | N/A | Jul 30, 2013 |
30MG | tablet | Discontinued | ORAL | N/A | Jul 30, 2013 |
5MG | tablet | Discontinued | ORAL | N/A | Jul 30, 2013 |
10MG | tablet | Discontinued | ORAL | N/A | Jul 30, 2013 |
40MG | tablet | Discontinued | ORAL | N/A | Jul 30, 2013 |
5. RISING
Rising Pharma Holdings Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Rising.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
2.5MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
5MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
10MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
20MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
30MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
40MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
6. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
2.5MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
5MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
10MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
20MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
30MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
40MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
7. WATSON LABS
Watson Laboratories Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Watson Labs.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
2.5MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
5MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
10MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
20MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
30MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
40MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
8. INVAGEN PHARMS
Invagen Pharmaceuticals Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Invagen Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
30MG | tablet | Prescription | ORAL | AB | Oct 29, 2013 |
2.5MG | tablet | Prescription | ORAL | AB | Oct 29, 2013 |
5MG | tablet | Prescription | ORAL | AB | Oct 29, 2013 |
10MG | tablet | Prescription | ORAL | AB | Oct 29, 2013 |
20MG | tablet | Prescription | ORAL | AB | Oct 29, 2013 |
40MG | tablet | Prescription | ORAL | AB | Oct 29, 2013 |
9. TEVA
Teva Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Teva.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
2.5MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
5MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
10MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
20MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
30MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
40MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
10. SUN PHARM INDS LTD
Sun Pharmaceutical Industries Ltd has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
2.5MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
5MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
10MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
20MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
40MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
30MG | tablet | Prescription | ORAL | AB | Feb 11, 2003 |
11. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Strides Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
2.5MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
5MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
10MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
20MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
30MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
40MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2002 |
12. WOCKHARDT BIO AG
Wockhardt Bio Ag has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Wockhardt Bio Ag.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
40MG | tablet | Prescription | ORAL | AB | Apr 19, 2007 |
2.5MG | tablet | Prescription | ORAL | AB | Apr 19, 2007 |
5MG | tablet | Prescription | ORAL | AB | Apr 19, 2007 |
10MG | tablet | Prescription | ORAL | AB | Apr 19, 2007 |
20MG | tablet | Prescription | ORAL | AB | Apr 19, 2007 |
30MG | tablet | Prescription | ORAL | AB | Apr 19, 2007 |
13. SCIEGEN PHARMS INC
Sciegen Pharmaceuticals Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
2.5MG | tablet | Prescription | ORAL | AB | Sep 15, 2020 |
10MG | tablet | Prescription | ORAL | AB | Sep 15, 2020 |
5MG | tablet | Prescription | ORAL | AB | Sep 15, 2020 |
40MG | tablet | Prescription | ORAL | AB | Mar 4, 2021 |
30MG | tablet | Prescription | ORAL | AB | Mar 4, 2021 |
20MG | tablet | Prescription | ORAL | AB | Mar 4, 2021 |
14. COREPHARMA
Corepharma Llc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Corepharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
2.5MG | tablet | Prescription | ORAL | AB | Sep 30, 2002 |
40MG | tablet | Prescription | ORAL | AB | Sep 30, 2002 |
30MG | tablet | Prescription | ORAL | AB | Sep 30, 2002 |
20MG | tablet | Prescription | ORAL | AB | Sep 30, 2002 |
10MG | tablet | Prescription | ORAL | AB | Sep 30, 2002 |
5MG | tablet | Prescription | ORAL | AB | Sep 30, 2002 |
15. ASCENT PHARMS INC
Ascent Pharmaceuticals Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Ascent Pharms Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
2.5MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
10MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
20MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
30MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
40MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
5MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
16. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Prinston Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
2.5MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
5MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
10MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
20MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
30MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
40MG | tablet | Prescription | ORAL | AB | Jul 1, 2002 |
17. AUROBINDO
Aurobindo Pharma Ltd has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Aurobindo.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG | tablet | Prescription | ORAL | AB | Feb 22, 2006 |
2.5MG | tablet | Prescription | ORAL | AB | Feb 22, 2006 |
10MG | tablet | Prescription | ORAL | AB | Feb 22, 2006 |
20MG | tablet | Prescription | ORAL | AB | Feb 22, 2006 |
30MG | tablet | Prescription | ORAL | AB | Feb 22, 2006 |
40MG | tablet | Prescription | ORAL | AB | Feb 22, 2006 |